Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2004-10-20 (21 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: AY-CHAMPAGNE (51150), Marne
PHARMACIE AGEENNE : revenue, balance sheet and financial ratios
PHARMACIE AGEENNE is a French company
founded 21 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in AY-CHAMPAGNE (51150),
this company of category PME
shows in 2019 a revenue of 2.3 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE AGEENNE (SIREN 479142028)
Indicator
2021
2020
2019
2018
2017
Revenue
N/C
N/C
2 338 396 €
2 369 380 €
1 951 678 €
Net income
206 827 €
216 383 €
228 068 €
254 628 €
210 128 €
EBITDA
N/C
N/C
190 131 €
236 415 €
109 849 €
Net margin
N/C
N/C
9.8%
10.7%
10.8%
Revenue and income statement
In 2021, PHARMACIE AGEENNE generates positive net income of 207 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2021: 210 k€ -> 207 k€.
Net income (2021)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
206 827 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 65%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 56%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2021)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
65.181%
Financial autonomy (2021)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
55.628%
Asset age ratio (2021)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
Debt ratio
207.687
139.847
102.302
76.717
65.181
Financial autonomy
30.697
38.448
46.238
52.653
55.628
Repayment capacity
10.008
8.276
6.665
None
None
Cash flow / Revenue
11.963%
9.839%
10.553%
None%
None%
Sector positioning
Debt ratio
65.182021
2019
2020
2021
Q1: 29.03
Med: 85.52
Q3: 208.44
Good-8 pts over 3 years
In 2021, the debt ratio of PHARMACIE AGEENNE (65.18) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
55.63%2021
2019
2020
2021
Q1: 25.89%
Med: 44.41%
Q3: 64.18%
Good+7 pts over 3 years
In 2021, the financial autonomy of PHARMACIE AGEENNE (55.6%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Repayment capacity
6.67 years2019
2019
Q1: 1.73 years
Med: 5.0 years
Q3: 9.48 years
Average
In 2019, the repayment capacity of PHARMACIE AGEENNE (6.67) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 177.53. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2021)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
177.526
Liquidity indicators evolution PHARMACIE AGEENNE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2020
2021
Liquidity ratio
189.294
170.602
168.68
158.595
177.526
Interest coverage
16.664
8.86
9.926
None
None
Sector positioning
Liquidity ratio
177.532021
2019
2020
2021
Q1: 139.2
Med: 190.68
Q3: 259.62
Average-7 pts over 3 years
In 2021, the liquidity ratio of PHARMACIE AGEENNE (177.53) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Interest coverage
9.93x2019
2019
Q1: 1.36x
Med: 5.41x
Q3: 11.35x
Good
In 2019, the interest coverage of PHARMACIE AGEENNE (9.9x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2021)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2021)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2021)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2021)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE AGEENNE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
Operating WCR
155 841 €
122 473 €
138 152 €
0 €
0 €
Inventory turnover (days)
26
24
21
0
0
Customer payment term (days)
2
3
2
0
0
Supplier payment term (days)
39
40
38
0
0
Positioning of PHARMACIE AGEENNE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 220 transactions of similar company sales
in 2021,
the value of PHARMACIE AGEENNE is estimated at
2 372 391 €
(range 1 525 459€ - 3 664 599€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2021
220 transactions
1525k€2372k€3664k€
2 372 391 €Range: 1 525 459€ - 3 664 599€
NAF 5 année 2021
Valuation method used
Net Income Multiple
206 827 €
×
11.5x
=2 372 392 €
Range: 1 525 460€ - 3 664 600€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE AGEENNE with other companies in the same sector:
Frequently asked questions about PHARMACIE AGEENNE
What is the revenue of PHARMACIE AGEENNE ?
The revenue of PHARMACIE AGEENNE in 2019 is 2.3 M€.
Is PHARMACIE AGEENNE profitable?
Yes, PHARMACIE AGEENNE generated a net profit of 207 k€ in 2021.
Where is the headquarters of PHARMACIE AGEENNE ?
The headquarters of PHARMACIE AGEENNE is located in AY-CHAMPAGNE (51150), in the department Marne.
Where to find the tax return of PHARMACIE AGEENNE ?
The tax return of PHARMACIE AGEENNE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE AGEENNE operate?
PHARMACIE AGEENNE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart